Atwood & Palmer Inc. lifted its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 67.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,853 shares of the company’s stock after purchasing an additional 17,653 shares during the period. Atwood & Palmer Inc.’s holdings in Colgate-Palmolive were worth $3,742,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of CL. YHB Investment Advisors Inc. boosted its stake in shares of Colgate-Palmolive by 388.0% during the 3rd quarter. YHB Investment Advisors Inc. now owns 51,377 shares of the company’s stock worth $4,383,000 after acquiring an additional 40,850 shares in the last quarter. Apella Capital LLC raised its stake in shares of Colgate-Palmolive by 312.2% in the 3rd quarter. Apella Capital LLC now owns 18,033 shares of the company’s stock valued at $1,539,000 after acquiring an additional 13,658 shares in the last quarter. Everhart Financial Group Inc. lifted its holdings in Colgate-Palmolive by 88.1% in the 3rd quarter. Everhart Financial Group Inc. now owns 8,694 shares of the company’s stock worth $742,000 after purchasing an additional 4,072 shares during the last quarter. Avidian Wealth Enterprises LLC boosted its position in Colgate-Palmolive by 89.1% during the third quarter. Avidian Wealth Enterprises LLC now owns 19,297 shares of the company’s stock worth $1,646,000 after purchasing an additional 9,094 shares during the period. Finally, Veracity Capital LLC grew its holdings in Colgate-Palmolive by 48.7% during the third quarter. Veracity Capital LLC now owns 11,169 shares of the company’s stock valued at $953,000 after purchasing an additional 3,660 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Stock Performance
NYSE:CL traded up $0.86 during trading hours on Thursday, hitting $88.07. 4,080,637 shares of the company traded hands, compared to its average volume of 5,703,748. The stock has a market capitalization of $70.21 billion, a price-to-earnings ratio of 34.95, a P/E/G ratio of 4.07 and a beta of 0.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The firm has a 50-day moving average of $89.23 and a 200 day moving average of $88.75. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is 84.13%.
Insider Buying and Selling at Colgate-Palmolive
In other news, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the sale, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John T. Cahill sold 4,170 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 in the last quarter. Corporate insiders own 0.43% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the stock. Barclays boosted their price objective on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. UBS Group boosted their target price on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating for the company in a report on Monday, August 3rd. Citigroup raised their price target on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Morgan Stanley reissued an “overweight” rating and set a $104.00 price objective on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Twelve analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.65.
Check Out Our Latest Analysis on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
